Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Comparison of clinical and surgical-pathological staging in IIIA non-small cell lung cancer patients.

Muehling B, Wehrmann C, Oberhuber A, Schelzig H, Barth T, Orend KH.

Ann Surg Oncol. 2012 Jan;19(1):89-93. doi: 10.1245/s10434-011-1895-9. Epub 2011 Jul 14.

PMID:
21755379
2.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
3.

The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.

Vesselle H, Pugsley JM, Vallières E, Wood DE.

J Thorac Cardiovasc Surg. 2002 Sep;124(3):511-9.

4.

FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.

Ryu JS, Choi NC, Fischman AJ, Lynch TJ, Mathisen DJ.

Lung Cancer. 2002 Feb;35(2):179-87.

PMID:
11804691
5.

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.

Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ.

Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S25-30.

PMID:
10536941
6.

The validity of preoperative lymph node staging guidelines of European Society of Thoracic Surgeons in non-small-cell lung cancer patients.

Gunluoglu MZ, Melek H, Medetoglu B, Demir A, Kara HV, Dincer SI.

Eur J Cardiothorac Surg. 2011 Aug;40(2):287-90. doi: 10.1016/j.ejcts.2010.11.030. Epub 2010 Dec 24.

PMID:
21185733
7.

Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.

Annema JT, Hoekstra OS, Smit EF, Veseliç M, Versteegh MI, Rabe KF.

Lung Cancer. 2004 Apr;44(1):53-60.

PMID:
15013583
8.

Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.

Iskender I, Kapicibasi HO, Kadioglu SZ, Sevilgen G, Tezel C, Kosar' A, Atasalihi A, Kir A.

Acta Chir Belg. 2012 May-Jun;112(3):219-25.

PMID:
22808763
9.

Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?

Casiraghi M, Travaini LL, Maisonneuve P, Tessitore A, Brambilla D, Agoglia BG, Guarize J, Spaggiari L.

Eur J Cardiothorac Surg. 2011 Apr;39(4):e38-43. doi: 10.1016/j.ejcts.2010.11.059. Epub 2011 Jan 15.

PMID:
21242094
10.

Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.

Darling GE, Maziak DE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, Gu CS, Kuruvilla MS, Cline KJ, Julian JA, Evans WK, Levine MN.

J Thorac Oncol. 2011 Aug;6(8):1367-72. doi: 10.1097/JTO.0b013e318220c912. Erratum in: J Thorac Oncol. 2012 Mar;7(3):628.

11.

Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.

Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altorki NK.

Ann Thorac Surg. 2007 Jul;84(1):177-81.

PMID:
17588407
12.

Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group.

Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE, Demedts MG.

Ann Thorac Surg. 1997 May;63(5):1441-50.

PMID:
9146340
13.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
14.

Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.

Cerfolio RJ, Bryant AS.

Ann Thorac Surg. 2008 Aug;86(2):362-6; discussion 366-7. doi: 10.1016/j.athoracsur.2008.04.042.

PMID:
18640297
15.

ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.

De Leyn P, Lardinois D, Van Schil PE, Rami-Porta R, Passlick B, Zielinski M, Waller DA, Lerut T, Weder W.

Eur J Cardiothorac Surg. 2007 Jul;32(1):1-8. Epub 2007 Apr 19.

PMID:
17448671
16.

Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.

Turk F, Gursoy S, Yaldiz S, Yuncu G, Yazgan S, Basok O.

Minerva Chir. 2011 Dec;66(6):509-16.

PMID:
22233657
17.

Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.

Watanabe S, Asamura H, Suzuki K, Tsuchiya R.

Ann Thorac Surg. 2005 May;79(5):1682-5.

PMID:
15854954
18.

Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.

Meyers BF, Haddad F, Siegel BA, Zoole JB, Battafarano RJ, Veeramachaneni N, Cooper JD, Patterson GA.

J Thorac Cardiovasc Surg. 2006 Apr;131(4):822-9; discussion 822-9. Epub 2006 Mar 2.

19.

A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size, and tumor markers.

Kimura H, Iwai N, Ando S, Kakizawa K, Yamamoto N, Hoshino H, Anayama T.

Ann Thorac Surg. 2003 Jun;75(6):1734-9.

PMID:
12822608

Supplemental Content

Support Center